Matches in Wikidata for { <http://www.wikidata.org/entity/Q92662870> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q92662870 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92662870 description "scientific article published on 13 August 2019" @default.
- Q92662870 description "wetenschappelijk artikel" @default.
- Q92662870 description "наукова стаття, опублікована 13 серпня 2019" @default.
- Q92662870 name "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 name "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 type Item @default.
- Q92662870 label "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 label "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 prefLabel "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 prefLabel "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 P1433 Q92662870-5C6DA3A8-5A43-4DAB-A42E-03E6CB0D858F @default.
- Q92662870 P1476 Q92662870-DC557EF3-058D-4800-AD23-91E09D9A46C7 @default.
- Q92662870 P2093 Q92662870-01C1487F-C227-4F7D-ABB2-70D382B7540E @default.
- Q92662870 P2093 Q92662870-3E6532E2-6E09-4B53-A83E-0250ED458B4A @default.
- Q92662870 P2093 Q92662870-462574DF-5061-469B-AB35-38B833EC345C @default.
- Q92662870 P2093 Q92662870-4732A52F-604A-4484-B8C4-7BB9E274C2B9 @default.
- Q92662870 P2093 Q92662870-490D5B4A-5711-4691-8EE7-97286F264F5D @default.
- Q92662870 P2093 Q92662870-B1AB9664-0728-4167-8387-735A29245B9E @default.
- Q92662870 P2093 Q92662870-B1EB68FA-C028-419B-9C96-530DEF96B34D @default.
- Q92662870 P2093 Q92662870-E1B203EF-1D57-49A9-9D96-7D78EFC38D83 @default.
- Q92662870 P304 Q92662870-6DA50DDE-4F71-4F07-9EFB-DA2CFE164DBC @default.
- Q92662870 P31 Q92662870-6DD40A59-C740-4BED-A222-559B742B729E @default.
- Q92662870 P356 Q92662870-B4ABD9D0-C5D8-4AE0-AB31-F726C2FEE1AC @default.
- Q92662870 P433 Q92662870-94BADB5C-7FBF-41B0-A7BB-742C7B24C348 @default.
- Q92662870 P478 Q92662870-A9D446E8-BC31-4F0A-B7EF-752C4B83F626 @default.
- Q92662870 P50 Q92662870-8A299532-FCAD-43D3-82AE-C099C35285BD @default.
- Q92662870 P50 Q92662870-938C7C79-A1E4-4253-A7A2-1475D8A11E05 @default.
- Q92662870 P577 Q92662870-AB050A84-5649-4AF5-B69D-5843F5736110 @default.
- Q92662870 P698 Q92662870-A8390AAE-AAB5-4B7D-B300-7EC8CDC366F7 @default.
- Q92662870 P921 Q92662870-98D96388-0CE2-4B48-8CF1-68277DC38F75 @default.
- Q92662870 P356 J.CGH.2019.08.012 @default.
- Q92662870 P698 31419574 @default.
- Q92662870 P1433 Q5133759 @default.
- Q92662870 P1476 "Stopping Mesalamine Therapy in Patients With Crohn's Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes" @default.
- Q92662870 P2093 "Berkeley N Limketkai" @default.
- Q92662870 P2093 "Camilla Bjørn Jensen" @default.
- Q92662870 P2093 "Clara Yzet" @default.
- Q92662870 P2093 "Jean-Frederic Colombel" @default.
- Q92662870 P2093 "Manasi Agrawal" @default.
- Q92662870 P2093 "Ryan C Ungaro" @default.
- Q92662870 P2093 "Thomas Ullman" @default.
- Q92662870 P2093 "Tine Jess" @default.
- Q92662870 P304 "1152-1160.e1" @default.
- Q92662870 P31 Q13442814 @default.
- Q92662870 P356 "10.1016/J.CGH.2019.08.012" @default.
- Q92662870 P433 "5" @default.
- Q92662870 P478 "18" @default.
- Q92662870 P50 Q49489697 @default.
- Q92662870 P50 Q56457877 @default.
- Q92662870 P577 "2019-08-13T00:00:00Z" @default.
- Q92662870 P698 "31419574" @default.
- Q92662870 P921 Q1472 @default.